This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
nervous system | 1627 |
multiple sclerosis | 1491 |
central nervous | 1246 |
spinal cord | 1205 |
virus infection | 561 |
clinical signs | 545 |
immune response | 517 |
mg kg | 514 |
bone marrow | 485 |
white matter | 451 |
transgenic mice | 402 |
results suggest | 394 |
gene expression | 367 |
brain barrier | 347 |
class i | 337 |
demyelinating disease | 335 |
viral infection | 333 |
immune responses | 329 |
glial cells | 327 |
ms patients | 321 |
cerebrospinal fluid | 319 |
design method | 318 |
infected mice | 317 |
mhc class | 316 |
experimental autoimmune | 316 |
hepatitis virus | 307 |
autoimmune encephalomyelitis | 304 |
immune system | 276 |
viral infections | 272 |
mouse hepatitis | 270 |
research funds | 268 |
nitric oxide | 263 |
united states | 261 |
cell death | 260 |
class ii | 257 |
present study | 256 |
cell responses | 254 |
nk cells | 246 |
endothelial cells | 240 |
respiratory syndrome | 235 |
west nile | 232 |
acute respiratory | 230 |
basic protein | 228 |
immune cells | 218 |
inflammatory response | 218 |
myelin basic | 218 |
growth factor | 214 |
nile virus | 210 |
type i | 209 |
specific cd | 208 |
animal models | 207 |
important role | 204 |
cell types | 197 |
borna disease | 196 |
stem cell | 193 |
schwann cells | 192 |
may also | 190 |
microglial cells | 189 |
peripheral blood | 188 |
spinal cords | 184 |
th cells | 183 |
cell lines | 182 |
inflammatory cytokines | 181 |
chemokine receptor | 176 |
graduate school | 174 |
mice infected | 173 |
innate immune | 172 |
chemokine receptors | 171 |
viral replication | 170 |
infected cells | 169 |
severe acute | 167 |
results indicate | 164 |
deficient mice | 164 |
necrosis factor | 162 |
pediatric patients | 161 |
mouse model | 160 |
dendritic cells | 159 |
risk factors | 158 |
lymph nodes | 157 |
human coronavirus | 156 |
cord injury | 154 |
progenitor cells | 153 |
reactive astrocytes | 149 |
states background | 148 |
tumor necrosis | 148 |
olfactory bulb | 147 |
cell response | 146 |
brain injury | 146 |
induced demyelination | 145 |
viral encephalitis | 142 |
stem cells | 141 |
viral rna | 141 |
optic nerve | 140 |
experimental allergic | 139 |
magnetic resonance | 138 |
data suggest | 137 |
cell proliferation | 137 |
disease virus | 137 |
ko mice | 137 |
infectious virus | 136 |
doc id | 136 |
cord uid | 136 |
allergic encephalomyelitis | 135 |
activated microglia | 135 |
cell surface | 134 |
kg iv | 131 |
measles virus | 130 |
herpes simplex | 130 |
virus replication | 130 |
cd foxp | 129 |
jhmv infection | 127 |
cerebral cortex | 126 |
bl mice | 126 |
inflammatory cells | 125 |
cell line | 124 |
myeloid cells | 124 |
adaptive immune | 123 |
syndrome coronavirus | 122 |
coronavirus infection | 122 |
rat brain | 121 |
recent studies | 121 |
molecular mimicry | 120 |
brain tissue | 120 |
respiratory tract | 119 |
mrna expression | 118 |
influenza virus | 118 |
respiratory distress | 117 |
side effects | 117 |
autoimmune disease | 116 |
positive cells | 116 |
amino acid | 115 |
coronavirus disease | 114 |
may play | 114 |
flow cytometry | 114 |
cns infection | 114 |
may contribute | 112 |
brain stem | 112 |
animal model | 111 |
neurological symptoms | 111 |
mononuclear cells | 110 |
wt mice | 110 |
novel coronavirus | 110 |
disease progression | 109 |
brain regions | 109 |
monoclonal antibodies | 109 |
cx cr | 109 |
oxide synthase | 108 |
median age | 107 |
neurological manifestations | 107 |
virus infections | 107 |
following infection | 106 |
clinical trials | 106 |
ml kg | 106 |
neuronal activity | 106 |
monoclonal antibody | 106 |
persistent infection | 106 |
neurodegenerative diseases | 105 |
high levels | 105 |
major histocompatibility | 104 |
murine coronavirus | 104 |
nipah virus | 104 |
cell activation | 104 |
cells may | 103 |
mean age | 103 |
mouse brain | 103 |
blood pressure | 103 |
viral clearance | 103 |
tcr transgenic | 103 |
sickle cell | 103 |
findings suggest | 102 |
human brain | 102 |
resonance imaging | 102 |
one patient | 101 |
significantly increased | 101 |
cns inflammation | 100 |
viral antigen | 99 |
pulmonary edema | 99 |
ms lesions | 98 |
previous studies | 98 |
encephalomyelitis virus | 98 |
microglial activation | 98 |
host defense | 98 |
immunodeficiency virus | 97 |
wnv infection | 97 |
determine whether | 97 |
cell type | 96 |
cell adhesion | 96 |
cells within | 96 |
proinflammatory cytokines | 94 |
cns disease | 94 |
ex vivo | 94 |
oxidative stress | 93 |
induced demyelinating | 93 |
cd th | 93 |
infectious diseases | 92 |
cell receptor | 92 |
molecular mechanisms | 92 |
critical role | 92 |
neurotropic viruses | 92 |
murine encephalomyelitis | 91 |
neurotropic coronavirus | 91 |
simplex virus | 91 |
cns cells | 91 |
mhv infection | 91 |
wild type | 90 |
may occur | 90 |
feline infectious | 89 |
transcription factor | 89 |
increased risk | 89 |
control mice | 89 |
adoptive transfer | 89 |
nk cell | 89 |
amino acids | 88 |
infectious peritonitis | 88 |
significantly higher | 88 |
glial cell | 88 |
hippocampal neurons | 88 |
neurological disease | 87 |
retrospective study | 87 |
gray matter | 87 |
neuronal death | 87 |
neutralizing antibodies | 87 |
peripheral nervous | 87 |
je progression | 87 |
antigen presentation | 87 |
inflammatory responses | 86 |
histocompatibility complex | 86 |
one cat | 86 |
clinical disease | 86 |
cell transplantation | 86 |
tissue damage | 86 |
mice showed | 86 |
foxp tregs | 86 |
situ hybridization | 85 |
blood cell | 85 |
knockout mice | 85 |
cytokine storm | 85 |
also found | 85 |
case series | 84 |
days post | 84 |
weight loss | 84 |
neural stem | 84 |
respiratory syncytial | 83 |
physical examination | 82 |
natural killer | 82 |
adhesion molecule | 82 |
japanese encephalitis | 82 |
mg dl | 82 |
disease severity | 82 |
growth factors | 81 |
acute infection | 81 |
significantly reduced | 81 |
myelin sheath | 81 |
body weight | 81 |
activated charcoal | 81 |
orogastric lavage | 80 |
purkinje cells | 80 |
cns involvement | 80 |
cell migration | 80 |
cell disease | 80 |
neurological signs | 80 |
adhesion molecules | 79 |
cell clones | 79 |
may result | 79 |
previously described | 79 |
viral load | 79 |
case report | 79 |
taken together | 79 |
fl fl | 79 |
brain parenchyma | 78 |
cell infiltration | 78 |
mice lacking | 78 |
significant increase | 78 |
sclerosis patients | 78 |
epithelial cells | 78 |
lymphocytic choriomeningitis | 78 |
stimulating factor | 78 |
middle east | 78 |
virus type | 78 |
syncytial virus | 78 |
synaptic plasticity | 78 |
cell populations | 77 |
clinical symptoms | 77 |
significant differences | 77 |
optic neuritis | 77 |
cortical neurons | 77 |
cerebral ischemia | 76 |
neurological diseases | 76 |
respiratory failure | 76 |
blood vessels | 76 |
axonal transport | 76 |
encephalitis virus | 76 |
respiratory viruses | 75 |
autoimmune diseases | 75 |
hi monocytes | 75 |
mrna levels | 75 |
neurological disorders | 75 |
rna viruses | 75 |
statistically significant | 75 |
lymph node | 75 |
cell population | 74 |
national institute | 74 |
synaptic transmission | 74 |
type mice | 74 |
systematic review | 74 |
neuronal cell | 74 |
choroid plexus | 74 |
mechanisms underlying | 74 |
kg po | 74 |
renal failure | 73 |
peripheral nerve | 73 |
mbp tcr | 73 |
hematopoietic stem | 73 |
clinical features | 73 |
electron microscopy | 73 |
blood flow | 73 |
treated mice | 72 |
low levels | 72 |
east respiratory | 72 |
cells expressing | 72 |
corpus callosum | 71 |
two patients | 71 |
cells isolated | 71 |
transcription factors | 71 |
prefrontal cortex | 71 |
neurological complications | 71 |
kg day | 71 |
previously reported | 71 |
substantia nigra | 71 |
cytokine production | 71 |
barr virus | 71 |
schwann cell | 70 |
years old | 70 |
virus encephalitis | 70 |
time points | 69 |
cell subsets | 69 |
progressive ms | 69 |
protein kinase | 69 |
disease process | 69 |
precursor cells | 69 |
soft tissue | 69 |
red blood | 69 |
ctl escape | 68 |
viral persistence | 68 |
two cats | 68 |
chart review | 68 |
human immunodeficiency | 68 |
intravenous fluids | 67 |
basal ganglia | 67 |
coronavirus oc | 67 |
acute encephalitis | 67 |
motor neurons | 67 |
receptor antagonist | 67 |
ifnar fl | 67 |
pediatric oncology | 67 |
environmental factors | 67 |
also observed | 67 |
neurotrophic factor | 67 |
clinical characteristics | 66 |
neuronal damage | 66 |
neuronal cells | 66 |
cd cells | 66 |
patients received | 66 |
matrix metalloproteinase | 66 |
gastrointestinal tract | 66 |
human coronaviruses | 66 |
mouse models | 66 |
cns infections | 66 |
increased expression | 65 |
highly expressed | 65 |
research institute | 65 |
case reports | 65 |
glial fibrillary | 65 |
cd cd | 65 |
expression levels | 65 |
neural cells | 64 |
choriomeningitis virus | 64 |
cell count | 64 |
demyelinating lesions | 64 |
microglia activation | 64 |
per cent | 64 |
also known | 64 |
may lead | 64 |
brain science | 64 |
acidic protein | 64 |
viral antigens | 64 |
severe disease | 64 |
innate immunity | 64 |
presenting cells | 64 |
platelet count | 63 |
protein expression | 63 |
see section | 63 |
rlcmv indg | 63 |
performed using | 63 |
memory cd | 63 |
western blot | 63 |
significant difference | 63 |
nmda receptor | 63 |
acute phase | 63 |
dentate gyrus | 63 |
microglia macrophages | 63 |
least one | 62 |
visual cortex | 62 |
cell lymphoma | 62 |
high risk | 62 |
risk factor | 62 |
demyelinating diseases | 62 |
old male | 61 |
protein concentration | 61 |
differential diagnosis | 61 |
fibrillary acidic | 61 |
i interferon | 61 |
plasma membrane | 61 |
transgenic mouse | 61 |
amyotrophic lateral | 61 |
target cells | 61 |
blood brain | 61 |
ng ml | 61 |
clinical trial | 61 |
computed tomography | 61 |
rabies virus | 61 |
sjl mice | 60 |
retrospective chart | 60 |
cns infiltration | 60 |
data indicate | 60 |
axonal damage | 60 |
remains unclear | 60 |
analysis revealed | 60 |
lateral sclerosis | 60 |
long term | 60 |
abdominal pain | 59 |
results show | 59 |
grey matter | 59 |
dependent manner | 59 |
several studies | 59 |
supplemental oxygen | 59 |
polymerase chain | 58 |
adult mice | 58 |
chain reaction | 58 |
immune cell | 58 |
mediated demyelination | 58 |
clinical course | 58 |
lineage cells | 58 |
dorsal root | 57 |
host cell | 57 |
marrow transplantation | 57 |
myelin sheaths | 57 |
motor neuron | 57 |
resident microglia | 57 |
hendra virus | 57 |
may provide | 57 |
binding protein | 57 |
rl mice | 57 |
cell apoptosis | 57 |
pleural effusion | 57 |
may cause | 57 |
lewis rats | 57 |
sclerosis lesions | 57 |
poorly understood | 57 |
viral proteins | 56 |
neuropathic pain | 56 |
blood cells | 56 |
converting enzyme | 56 |
flow cytometric | 56 |
chemoattractant protein | 56 |
monocyte chemoattractant | 56 |
infected animals | 56 |
tumor cells | 56 |
signal transduction | 56 |
cell cultures | 56 |
significantly decreased | 55 |
heart rate | 55 |
olfactory epithelium | 55 |
myelin antigens | 55 |
fl mice | 55 |
even though | 55 |
signaling pathway | 55 |
lymphoblastic leukemia | 55 |
high dose | 55 |
recent study | 55 |
large number | 54 |
spike protein | 54 |
ischemic stroke | 54 |
disease activity | 54 |
mutant mice | 54 |
monocytes macrophages | 54 |
extracellular matrix | 53 |
escape mutants | 53 |
acute lymphoblastic | 53 |
early stages | 53 |
neural cell | 53 |
studies suggest | 53 |
ng cells | 53 |
hemophagocytic lymphohistiocytosis | 53 |
time course | 53 |
inducible nitric | 53 |
transforming growth | 53 |
disseminated encephalomyelitis | 53 |
sensory neurons | 53 |
pyramidal neurons | 53 |
viral encephalomyelitis | 53 |
progressive multiple | 53 |
three patients | 53 |
epitope spreading | 53 |
resident cells | 53 |
forest virus | 52 |
inflammatory demyelinating | 52 |
patients treated | 52 |
nerve injury | 52 |
neutralizing antibody | 52 |
traumatic brain | 52 |
young adults | 52 |
semliki forest | 52 |
sciatic nerve | 51 |
reactive oxygen | 51 |
infected patients | 51 |
infectious agents | 51 |
protective role | 51 |
disease course | 51 |
days later | 51 |
key role | 51 |
specific antibodies | 51 |
well known | 51 |
proteolipid protein | 50 |
patients receiving | 50 |
cellular immune | 50 |
neurologic disease | 50 |
osaka univ | 50 |
evidence suggests | 50 |
ccr mice | 50 |
host immune | 50 |
viral spread | 50 |
pediatric population | 50 |
hippocampal slices | 50 |
chronic demyelination | 50 |
mice compared | 50 |
matrix metalloproteinases | 50 |
human respiratory | 50 |
ca region | 49 |
cd expression | 49 |
jev infection | 49 |
ependymal cells | 49 |
pediatr radiol | 49 |
mr imaging | 49 |
persistently infected | 49 |
infiltrating macrophages | 49 |
white blood | 49 |
mice exhibited | 49 |
studies using | 49 |
lower respiratory | 49 |
myelin protein | 49 |
brain function | 49 |
effector function | 49 |
overall survival | 49 |
old female | 49 |
brain tumors | 49 |
pd patients | 48 |
cns disorders | 48 |
systemic inflammation | 48 |
myelin proteins | 48 |
commonly used | 48 |
crucial role | 48 |
positron emission | 48 |
pet ct | 48 |
rheumatoid arthritis | 48 |
granule cells | 48 |
neurite outgrowth | 48 |
functional recovery | 48 |
effector cells | 48 |
acute disseminated | 48 |
cc chemokine | 48 |
cns tissue | 48 |
brain development | 48 |
important roles | 47 |
remitting multiple | 47 |
opc differentiation | 47 |
specific ctl | 47 |
prospective study | 47 |
university graduate | 47 |
progressive multifocal | 47 |
results demonstrate | 47 |
induce emesis | 47 |
cns viral | 47 |
urinary tract | 47 |
clinical presentation | 47 |
acute viral | 47 |
mechanical ventilation | 47 |
plasma cells | 47 |
diagnostic criteria | 47 |
brain lesions | 47 |
two groups | 47 |
childhood cancer | 47 |
cd hi | 47 |
inflammatory monocytes | 47 |
university school | 47 |
medical center | 47 |
signaling pathways | 47 |
tg mice | 46 |
kyoto university | 46 |
infected neurons | 46 |
jhm virus | 46 |
significantly lower | 46 |
oligodendrocyte glycoprotein | 46 |
patients may | 46 |
mice deficient | 46 |
mice treated | 46 |
whole blood | 46 |
ablated mice | 46 |
adult brain | 46 |
cns parenchyma | 46 |
cell function | 46 |
cns resident | 46 |
ccr cd | 46 |
viral burden | 46 |
chronic demyelinating | 46 |
myelin oligodendrocyte | 46 |
severe cases | 46 |
significantly different | 45 |
chronic progressive | 45 |
normal mice | 45 |
will discuss | 45 |
two different | 45 |
first case | 45 |
ct scan | 45 |
previously shown | 45 |
respiratory depression | 45 |
vast majority | 45 |
mgfapcre ifnar | 45 |
relapse rate | 45 |
ctl response | 45 |
i ifn | 45 |
macrophage infiltration | 45 |
cells ml | 45 |
within days | 45 |
days postinfection | 44 |
new york | 44 |
csf samples | 44 |
one study | 44 |
inflammatory cytokine | 44 |
analyzed using | 44 |
may help | 44 |
pyramidal cells | 44 |
inflammatory disease | 44 |
multifocal leukoencephalopathy | 44 |
nmda receptors | 44 |
membrane potential | 44 |
three cats | 44 |
another study | 44 |
perform orogastric | 44 |
infection may | 44 |
multiple myeloma | 44 |
viral particles | 44 |
four patients | 44 |
dopaminergic neurons | 44 |
disease onset | 43 |
post mortem | 43 |
mental status | 43 |
rna virus | 43 |
humoral immunity | 43 |
head trauma | 43 |
murine hepatitis | 43 |
cell bodies | 43 |
demyelination induced | 43 |
tyrosine kinase | 43 |
chemokine expression | 43 |
cell culture | 43 |
give rise | 43 |
inflammatory diseases | 43 |
protein levels | 43 |
killer cells | 43 |
intranasal inoculation | 42 |
like receptors | 42 |
inflammatory protein | 42 |
two distinct | 42 |
gamma interferon | 42 |
derived cells | 42 |
mononuclear cell | 42 |
clinical practice | 42 |
increased levels | 42 |
public health | 42 |
dengue virus | 42 |
zika virus | 42 |
inflammatory cell | 42 |
myasthenia gravis | 42 |
antibody response | 42 |
coronavirus infections | 42 |
viral control | 42 |
morphological changes | 42 |
may reflect | 42 |
csf protein | 42 |
administer intravenous | 42 |
peripheral nerves | 42 |
cns demyelination | 42 |
brain cells | 42 |
imaging findings | 42 |
receptor binding | 42 |
oncology patients | 42 |
studies indicate | 41 |
upper respiratory | 41 |
limb paralysis | 41 |
emission tomography | 41 |
science institute | 41 |
analysis showed | 41 |
increased mortality | 41 |
intensive care | 41 |
murine model | 41 |
neuronal injury | 41 |
different types | 41 |
rat spinal | 41 |
peripheral immune | 41 |
study group | 41 |
fluid therapy | 41 |
virus clearance | 41 |
binding sites | 41 |
rat model | 41 |
oligodendrocyte precursor | 41 |
ido ko | 41 |
cell cycle | 41 |
specific antibody | 41 |
axonal injury | 41 |
macrophage inflammatory | 41 |
high frequency | 41 |
results showed | 41 |
cognitive impairment | 41 |
study showed | 41 |
also occur | 41 |
secondary progressive | 41 |
adult rats | 41 |
glial activation | 41 |
stranded rna | 41 |
viral titers | 41 |
inflammatory mediators | 41 |
possible role | 41 |
naturally occurring | 41 |
may represent | 41 |
controlled trial | 40 |
receptor expression | 40 |
crystalloid fluids | 40 |
central role | 40 |
cns diseases | 40 |
fatty acids | 40 |
total number | 40 |
low dose | 40 |
multiple organ | 40 |
whenever possible | 40 |
tissue injury | 40 |
year old | 40 |
findings indicate | 40 |
chronic inflammatory | 40 |
olfactory nerve | 40 |
i expression | 40 |
distress syndrome | 40 |
higher levels | 40 |
wide range | 40 |
brain mri | 40 |
antibody responses | 40 |
potential role | 40 |
described previously | 40 |
inflammatory reaction | 40 |
jhm infection | 40 |
cell transplant | 40 |
newly diagnosed | 40 |
gnrh neurons | 40 |
vaccinia virus | 40 |
factor viii | 40 |
neuronal loss | 40 |
immune surveillance | 39 |
axonal degeneration | 39 |
fdg uptake | 39 |
apoptotic cells | 39 |
rat hippocampal | 39 |
neurologic manifestations | 39 |
cerebral artery | 39 |
receptor ccr | 39 |
incubation period | 39 |
widely used | 39 |
within hours | 39 |
psychiatric disorders | 39 |
metabolic acidosis | 39 |
elevated protein | 39 |
matter lesions | 39 |
tmev infection | 39 |
lethal infection | 39 |
major role | 39 |
many patients | 39 |
focal cerebral | 39 |
data demonstrate | 39 |
dth response | 39 |
clinical score | 39 |
cns injury | 39 |
cns via | 39 |
cns pathology | 38 |
mm hg | 38 |
cellular immunity | 38 |
adult cns | 38 |
kg hour | 38 |
mice expressing | 38 |
oxygen species | 38 |
antigen expression | 38 |
may include | 38 |
four cats | 38 |
elevated levels | 38 |
microglial cell | 38 |
foreign bodies | 38 |
plasma cell | 38 |
protective effect | 38 |
cytometric analysis | 38 |
immune activation | 38 |
infection induces | 38 |
pet imaging | 38 |
respiratory infections | 38 |
immunocompromised patients | 38 |
mediated immune | 38 |
protein gene | 38 |
therapeutic strategies | 38 |
severe covid | 37 |
coronavirus jhm | 37 |
medical university | 37 |
zoster virus | 37 |
general anesthesia | 37 |
significant decrease | 37 |
glatiramer acetate | 37 |
cerebral blood | 37 |
kg minute | 37 |
chronic pain | 37 |
expression pattern | 37 |
sars coronavirus | 37 |
astrocyte activation | 37 |
among patients | 37 |
oligodendrocyte progenitor | 37 |
hospitalized patients | 37 |
high affinity | 37 |
hemolytic anemia | 37 |
hpa axis | 37 |
experimental models | 37 |
pilot study | 37 |
subacute sclerosing | 37 |
cells express | 37 |
adult patients | 37 |
myeloid leukemia | 37 |
temporal lobe | 37 |
single cell | 37 |
immunohistochemical staining | 36 |
cell differentiation | 36 |
cxc chemokine | 36 |
previous study | 36 |
toxoplasma gondii | 36 |
neurodegenerative disorders | 36 |
acute disease | 36 |
iron overload | 36 |
ii expression | 36 |
bipolar disorder | 36 |
studies showed | 36 |
myelin loss | 36 |
many cases | 36 |
control subjects | 36 |
csf analysis | 36 |
neurodegenerative disease | 36 |
cells derived | 36 |
healthy controls | 36 |
infectious disease | 36 |
patients without | 36 |
mri findings | 36 |
supportive care | 36 |
cns lesions | 36 |
molecular basis | 36 |
room temperature | 36 |
expression profiles | 36 |
clinical manifestations | 36 |
young adult | 36 |
mediated immunity | 36 |
pathological conditions | 36 |
cell membrane | 36 |
may require | 35 |
hla class | 35 |
five patients | 35 |
family history | 35 |
normal brain | 35 |
cells specific | 35 |
ca i | 35 |
autoimmune response | 35 |
cells also | 35 |
expression patterns | 35 |
cerebral edema | 35 |
motor function | 35 |
mature oligodendrocytes | 35 |
type ii | 35 |
pediatric hematology | 35 |
time point | 35 |
cytokine expression | 35 |
bacterial infection | 35 |
lewis rat | 35 |
renal function | 35 |
brain damage | 35 |
bd biosciences | 35 |
functional role | 35 |
examined whether | 35 |
middle cerebral | 35 |
microglia may | 35 |
expressing cells | 35 |
remains unknown | 35 |
young children | 35 |
mhc molecules | 35 |
mouse strains | 35 |
potential therapeutic | 35 |
staggering disease | 35 |
osaka university | 35 |
optic nerves | 35 |
glutamate receptors | 35 |
blood count | 35 |
jhm strain | 35 |
depleted mice | 35 |
system infection | 35 |
developing brain | 35 |
radiation therapy | 35 |
primary demyelination | 35 |
hearing loss | 35 |
surface expression | 35 |
significant reduction | 35 |
demyelinating encephalomyelitis | 34 |
ctl responses | 34 |
derived neurotrophic | 34 |
virus strain | 34 |
ii molecules | 34 |
saline solution | 34 |
family members | 34 |
glutamate transporters | 34 |
better understand | 34 |
hippocampal ca | 34 |
adaptive immunity | 34 |
pediatric cancer | 34 |
neurological deficits | 34 |
endoplasmic reticulum | 34 |
action potentials | 34 |
adult mouse | 34 |
acute myeloid | 34 |
nerve growth | 34 |
sendai virus | 34 |
chronic infection | 34 |
humoral immune | 34 |
better understanding | 34 |
pc cells | 34 |
cns tissues | 34 |
protein synthesis | 34 |
cns myelin | 34 |
heart failure | 34 |
growth cone | 34 |
cell recruitment | 34 |
higher risk | 34 |
central venous | 34 |
nine patients | 34 |
effector functions | 34 |
yellow fever | 34 |
myelin damage | 34 |
infectious agent | 34 |
wide variety | 34 |
foreign body | 34 |
cohort study | 34 |
lymphoid tissue | 34 |
intravenous crystalloid | 33 |
clinical diagnosis | 33 |
cell survival | 33 |
immunohistochemical analysis | 33 |
patients infected | 33 |
data support | 33 |
poor prognosis | 33 |
like cells | 33 |
fty treatment | 33 |
sclerosing panencephalitis | 33 |
complete blood | 33 |
rubella virus | 33 |
fold increase | 33 |
cytokine release | 33 |
leading cause | 33 |
tspo expression | 33 |
cns tumors | 33 |
retrospective review | 33 |
dendritic cell | 33 |
human cns | 33 |
world health | 33 |
fatty acid | 33 |
antigen presenting | 33 |
chronic relapsing | 33 |
neoplastic cells | 33 |
statistical significance | 33 |
mg ml | 33 |
health care | 33 |
data show | 33 |
vascular malformations | 33 |
clinical data | 33 |
kyoto univ | 33 |
postnatal day | 33 |
post infection | 33 |
flaccid paralysis | 33 |
six patients | 33 |
diabetes mellitus | 33 |
intracranial inoculation | 33 |
control group | 33 |
bdv infection | 33 |
disease caused | 33 |
see chapter | 33 |
microarray analysis | 33 |
tissue destruction | 33 |
demyelinated axons | 33 |
axonal loss | 33 |
adverse effects | 33 |
may explain | 33 |
solid tumors | 33 |
day post | 33 |
one case | 33 |
glioma cells | 33 |
vascular endothelial | 33 |
pathogenic role | 33 |
signs associated | 33 |
vesicular stomatitis | 33 |
glutamate receptor | 33 |
i innate | 33 |
two cases | 33 |
many different | 33 |
body temperature | 32 |
tissue distribution | 32 |
tract infections | 32 |
statistical analysis | 32 |
spinal fluid | 32 |
well understood | 32 |
virus may | 32 |
respiratory system | 32 |
specific immune | 32 |
therapy may | 32 |
altered mental | 32 |
term potentiation | 32 |
opioid receptors | 32 |
gabaergic neurons | 32 |
reported cases | 32 |
cultured rat | 32 |
tohoku univ | 32 |
gold standard | 32 |
inflamed cns | 32 |
fluorescent protein | 32 |
glutamate transporter | 32 |
interferon gamma | 32 |
myeloid cell | 32 |
cd high | 32 |
cell help | 32 |
ischemic brain | 32 |
time pcr | 32 |
common cause | 32 |
human herpesvirus | 32 |
disease pathogenesis | 32 |
adult rat | 32 |
hiv infection | 32 |
proinflammatory cytokine | 32 |
precursor protein | 32 |
secondary hlh | 32 |
type astrocytes | 32 |
health organization | 32 |
early phase | 32 |
viral entry | 32 |
brain edema | 32 |
neuronal differentiation | 32 |
glutamate uptake | 32 |
anterior chamber | 32 |
macrophage colony | 32 |
interferon beta | 32 |
myelin components | 32 |
genetic factors | 32 |
macrophages microglia | 32 |
hemorrhagic fever | 32 |
predictive value | 32 |
syndrome associated | 32 |
virus entry | 32 |
clinical studies | 32 |
ad patients | 32 |
alpha beta | 32 |
activated macrophages | 31 |
without affecting | 31 |
slice cultures | 31 |
intravenous immunoglobulin | 31 |
fibroblast growth | 31 |
nucleic acid | 31 |
blood mononuclear | 31 |
chronic disease | 31 |
respiratory disease | 31 |
arterial blood | 31 |
also showed | 31 |
nude mice | 31 |
clinical outcomes | 31 |
vagus nerve | 31 |
expression level | 31 |
activated astrocytes | 31 |
following viral | 31 |
cells via | 31 |
cause severe | 31 |
electron microscopic | 31 |
results suggested | 31 |
infected brain | 31 |
stomatitis virus | 31 |
ng glia | 31 |
nucleated cell | 31 |
underlying cause | 31 |
care unit | 31 |
frontal cortex | 31 |
critically ill | 31 |
mortality rate | 31 |
muscle weakness | 31 |
brain tissues | 31 |
granule cell | 31 |
sequence analysis | 31 |
specific cytotoxic | 31 |
induced encephalomyelitis | 31 |
cell trafficking | 31 |
sindbis virus | 31 |
oligoclonal bands | 31 |
human metapneumovirus | 31 |
lupus erythematosus | 30 |
gene products | 30 |
small number | 30 |
cell counts | 30 |
differential expression | 30 |
cancer survivors | 30 |
immune function | 30 |
essential role | 30 |
different cell | 30 |
san diego | 30 |
persistent viral | 30 |
patients developed | 30 |
working memory | 30 |
research center | 30 |
see table | 30 |
pg ml | 30 |
cell entry | 30 |
niv infection | 30 |
i molecules | 30 |
neuronal degeneration | 30 |
total rna | 30 |
human disease | 30 |
serum albumin | 30 |
astrocytes may | 30 |
closely related | 30 |
tokyo metropolitan | 30 |
mechanisms involved | 30 |
showed significant | 30 |
blot analysis | 30 |
year period | 30 |
cervical lymph | 30 |
similar results | 30 |
thrombotic microangiopathy | 30 |
direct viral | 30 |
pathological changes | 30 |
increased viral | 30 |
evoked potentials | 30 |
patients diagnosed | 30 |
macrophage activation | 30 |
pcr analysis | 30 |
may induce | 30 |
carbon dioxide | 30 |
ev cases | 30 |
projection neurons | 30 |
therapeutic target | 30 |
cerebrovascular disease | 30 |
high doses | 30 |
play important | 30 |
tohoku university | 30 |
may become | 30 |
epidemiological studies | 29 |
platelet counts | 29 |
local anesthetic | 29 |
lymphoid organs | 29 |
canine distemper | 29 |
intracellular calcium | 29 |
less common | 29 |
patients showed | 29 |
imaging techniques | 29 |
severe respiratory | 29 |
new insights | 29 |
spastic paraparesis | 29 |
brain areas | 29 |
viral pathogenesis | 29 |
nerve conduction | 29 |
neural activity | 29 |
cardiac output | 29 |
complex class | 29 |
cell tumors | 29 |
strain jhm | 29 |
type iii | 29 |
unclear whether | 29 |
frozen plasma | 29 |
basement membrane | 29 |
like receptor | 29 |
neuronal infection | 29 |
also reported | 29 |
patient population | 29 |
urine output | 29 |
adverse events | 29 |
opioid receptor | 29 |
increased susceptibility | 29 |
susceptible mice | 29 |
unique teaching | 29 |
fresh frozen | 29 |
receptor cxcr | 29 |
ido ablation | 29 |
mice transgenic | 29 |
cell biology | 29 |
teaching points | 29 |
inflammatory processes | 29 |
primary cultures | 29 |
eye movement | 29 |
treatment consists | 29 |
effi cacy | 29 |
structural proteins | 29 |
case presentation | 29 |
study using | 29 |
antibody titers | 29 |
lesions may | 29 |
organ failure | 28 |
medical school | 28 |
pidd patients | 28 |
systemic lupus | 28 |
tight junctions | 28 |
surgical resection | 28 |
hi cd | 28 |
renal disease | 28 |
nerve terminals | 28 |
patients undergoing | 28 |
brain slices | 28 |
neuronal function | 28 |
often associated | 28 |
existing asc | 28 |
molecular mechanism | 28 |
among children | 28 |
ccl transgenic | 28 |
intravenous catheter | 28 |
jc virus | 28 |
cns following | 28 |
synapse formation | 28 |
medical records | 28 |
type hypersensitivity | 28 |
nagoya university | 28 |
transverse myelitis | 28 |
artery occlusion | 28 |
viral diseases | 28 |
small animal | 28 |
several days | 28 |
steady state | 28 |
lower levels | 28 |
riken brain | 28 |
intravenous fluid | 28 |
cranial nerve | 28 |
phase ii | 28 |
may act | 28 |
myelin debris | 28 |
future studies | 28 |
well documented | 28 |
neuronal apoptosis | 28 |
mortality rates | 28 |
literature review | 28 |
differential diagnoses | 28 |
patient developed | 28 |
gene encoding | 28 |
blood cultures | 28 |
significant role | 28 |
pathogenic mechanisms | 28 |
molecular weight | 28 |
molecular biology | 28 |
heart disease | 28 |
induced neuronal | 28 |
peripheral tissues | 28 |
inflammatory demyelination | 28 |
neural progenitor | 28 |
saudi arabia | 28 |
factor receptor | 28 |
intracellular ca | 28 |
control animals | 28 |
hind limb | 28 |
clinical improvement | 28 |
disease may | 28 |
beneficial effects | 28 |
also present | 28 |
informed consent | 28 |
lymphoid cells | 28 |
sterile saline | 28 |
related genes | 28 |
blood samples | 27 |
results indicated | 27 |
active ms | 27 |
lyme disease | 27 |
primary microglia | 27 |
brain sections | 27 |
induced cell | 27 |
host cells | 27 |
dna methylation | 27 |
per year | 27 |
cell body | 27 |
inflammatory process | 27 |
may affect | 27 |
inducible protein | 27 |
limbic system | 27 |
th cytokines | 27 |
also expressed | 27 |
neurological involvement | 27 |
skeletal muscle | 27 |
emergency care | 27 |
pediatric patient | 27 |
neutrophilic pleocytosis | 27 |
gap junction | 27 |
ampa receptors | 27 |
cx cl | 27 |
infection causes | 27 |
motor cortex | 27 |
oc infection | 27 |
dendritic spines | 27 |
made based | 27 |
cns inflammatory | 27 |
first step | 27 |
locomotor activity | 27 |
receptive field | 27 |
auditory cortex | 27 |
dorsal horn | 27 |
chemokine ligand | 27 |
spike glycoprotein | 27 |
investigated whether | 27 |
reactive protein | 27 |
infected rats | 27 |
wistar rats | 27 |
ctl activity | 27 |
neuronal survival | 27 |
amyloid precursor | 27 |
age years | 27 |
protective immunity | 27 |
much higher | 27 |
see also | 27 |
developing ms | 27 |
cord compression | 27 |
complement activation | 27 |
human ace | 27 |
oligodendrocyte lineage | 27 |
protein level | 27 |
olfactory sensory | 27 |
determined using | 27 |
study demonstrated | 27 |
high grade | 27 |
neurotropic virus | 27 |
tract infection | 27 |
whole body | 27 |
hodgkin lymphoma | 27 |
microglia cells | 26 |
antibiotic therapy | 26 |
human neural | 26 |
nontransgenic mice | 26 |
monocyte differentiation | 26 |
purkinje cell | 26 |
intravascular coagulation | 26 |
axonal regeneration | 26 |
antibody production | 26 |
mechanism underlying | 26 |
one year | 26 |
reactive gliosis | 26 |
associated myelopathy | 26 |
infiltrating cells | 26 |
cell mediated | 26 |
respiratory symptoms | 26 |
chronic inflammation | 26 |
cell infiltrates | 26 |
least three | 26 |
ms pathogenesis | 26 |
investigate whether | 26 |
well tolerated | 26 |
medical management | 26 |
mr images | 26 |
disseminated intravascular | 26 |
surface markers | 26 |
cov infection | 26 |
sclerosis brain | 26 |
foxp gfp | 26 |
early diagnosis | 26 |
evidence indicates | 26 |
tight junction | 26 |
cardiac dysrhythmias | 26 |
neuroinvasive potential | 26 |
decision making | 26 |
cns cell | 26 |
underlying mechanisms | 26 |
median time | 26 |
studies demonstrate | 26 |
smooth muscle | 26 |
antiviral immune | 26 |
status epilepticus | 26 |
glial scar | 26 |
definitive diagnosis | 26 |
two weeks | 26 |
thoracic radiographs | 26 |
also important | 26 |
low level | 26 |
behavioral abnormalities | 26 |
observations suggest | 26 |
wnv encephalitis | 26 |
alzheimer disease | 26 |
cell memory | 26 |
whole brain | 26 |
following intranasal | 26 |
endothelial cell | 26 |
term neurological | 26 |
gene transfer | 26 |
cells following | 26 |
head injury | 26 |
total protein | 26 |
inclusion criteria | 26 |
may develop | 26 |
cns may | 25 |
vitro studies | 25 |
pns myelin | 25 |
cell epitopes | 25 |
thyroid hormone | 25 |
cell activity | 25 |
root ganglia | 25 |
virus specific | 25 |
natural history | 25 |
one hundred | 25 |
authors declare | 25 |
severe neurological | 25 |
mice undergoing | 25 |
age group | 25 |
secreting cells | 25 |
cognitive function | 25 |
veterinary medicine | 25 |
different brain | 25 |
make sure | 25 |
washed twice | 25 |
old girl | 25 |
cell layer | 25 |
bbb permeability | 25 |
perivascular cuffing | 25 |
neurons showed | 25 |
relapsing experimental | 25 |
specific igg | 25 |
age groups | 25 |
rabbit anti | 25 |
one dog | 25 |
systemic inflammatory | 25 |
current study | 25 |
physical therapy | 25 |
equine encephalitis | 25 |
live attenuated | 25 |
induced neurologic | 25 |
weighted images | 25 |
gi tract | 25 |
treated patients | 25 |
control study | 25 |
imaging studies | 25 |
guinea pigs | 25 |
innate responses | 25 |
cytolytic activity | 25 |
drg neurons | 25 |
showed increased | 25 |
brain atrophy | 25 |
serum levels | 25 |
hematology oncology | 25 |
early postnatal | 25 |
brain activity | 25 |
receptor antagonists | 25 |
gain access | 25 |
gfap expression | 25 |
urinary catheter | 25 |
iv cri | 25 |
peripheral macrophages | 25 |
autoimmune responses | 25 |
years later | 25 |
suppurative meningoencephalitis | 25 |
immunodeficient mice | 25 |
lesion formation | 25 |
acute chest | 25 |
lactate dehydrogenase | 25 |
host response | 25 |
healthy subjects | 25 |
gc formation | 25 |
healthy individuals | 25 |
cells per | 25 |
ca pyramidal | 25 |
less likely | 25 |
progressive disease | 25 |
still unclear | 25 |
eae model | 25 |
airway obstruction | 25 |
leukocyte migration | 25 |
cultured astrocytes | 25 |
myelin destruction | 25 |
chest syndrome | 25 |
progenitor cell | 25 |
information processing | 25 |
mental disorders | 25 |
real time | 24 |
differentially expressed | 24 |
mmp expression | 24 |
two major | 24 |
recent advances | 24 |
early stage | 24 |
venezuelan equine | 24 |
marked increase | 24 |
naive mice | 24 |
free radicals | 24 |
eae mice | 24 |
protein concentrations | 24 |
significantly associated | 24 |
phase i | 24 |
less severe | 24 |
see later | 24 |
receptor activation | 24 |
cell sorting | 24 |
tissue culture | 24 |
cns damage | 24 |
activated cd | 24 |
barre syndrome | 24 |
infiltrating cd | 24 |
expression analysis | 24 |
north america | 24 |
astrocyte cultures | 24 |
different mechanisms | 24 |
mhc antigens | 24 |
primary cns | 24 |
adult male | 24 |
culture system | 24 |
encephalitis associated | 24 |
three days | 24 |
bovine serum | 24 |
marrow failure | 24 |
three cases | 24 |
mucous membranes | 24 |
various types | 24 |
plaque assay | 24 |
cyclic nucleotide | 24 |
following jhmv | 24 |
per patient | 24 |
signal intensity | 24 |
induce demyelination | 24 |
surface area | 24 |
primary progressive | 24 |
mouth disease | 24 |
compact myelin | 24 |
secondary lymphoid | 24 |
subventricular zone | 24 |
spleen cells | 24 |
major cause | 24 |
metastatic disease | 24 |
inflammatory factors | 24 |
acute encephalomyelitis | 24 |
general population | 24 |
olfactory dysfunction | 24 |
i mhc | 24 |
cxc chemokines | 24 |
pivotal role | 24 |
cell rna | 24 |
studies will | 24 |
i will | 24 |
survival rates | 24 |
rem sleep | 24 |
fi rst | 24 |
also demonstrated | 24 |
cortical areas | 24 |
facial nerve | 24 |
neurons may | 24 |
intervertebral disc | 24 |
life science | 24 |
hematopoietic cell | 24 |
clinically significant | 24 |
helper cells | 24 |
fusion protein | 24 |
programmed cell | 24 |
cd low | 24 |
examination revealed | 24 |
expression profile | 24 |
virus antigen | 24 |
human ms | 24 |
sclerosis multiple | 24 |
genetic background | 24 |
may appear | 24 |
kg body | 24 |
recently reported | 24 |
hi granulocytes | 24 |
days following | 24 |
cell depletion | 24 |
blood volume | 24 |
plasma exchange | 24 |
postnatal development | 23 |
infected astrocytes | 23 |
chronically infected | 23 |
immune suppression | 23 |
generation sequencing | 23 |
leukemia virus | 23 |
mhc expression | 23 |
rat astrocytes | 23 |
nasal cavity | 23 |
fetal mri | 23 |
heat shock | 23 |
ebola virus | 23 |
influenza viruses | 23 |
urinary bladder | 23 |
novel therapeutic | 23 |
neuronal migration | 23 |
functional receptor | 23 |
er stress | 23 |
nervous systems | 23 |
patients presenting | 23 |
may reveal | 23 |
neurotrophic factors | 23 |
specific asc | 23 |
maintain hydration | 23 |
free survival | 23 |
effective treatment | 23 |
neuronal dysfunction | 23 |
viral envelope | 23 |
reverse transcriptase | 23 |
recent years | 23 |
murine models | 23 |
antibody levels | 23 |
transplant recipients | 23 |
sodium channel | 23 |
th cytokine | 23 |
distemper virus | 23 |
side effect | 23 |
mental health | 23 |
viral protein | 23 |
glutamate release | 23 |
laboratory findings | 23 |
two types | 23 |
direct evidence | 23 |
neuromyelitis optica | 23 |
studies demonstrated | 23 |
pulmonary disease | 23 |
guinea pig | 23 |
renal perfusion | 23 |
associated glycoprotein | 23 |
therapeutic targets | 23 |
immune reaction | 23 |
neuropsychiatric disorders | 23 |
study suggests | 23 |
ct scans | 23 |
fever virus | 23 |
feline immunodeficiency | 23 |
gene therapy | 23 |
normal controls | 23 |
intracranial pressure | 23 |
brain tumor | 23 |
virus induced | 23 |
neural activities | 23 |
high incidence | 23 |
system disease | 23 |
spectrum antibiotics | 23 |
much less | 23 |
higher incidence | 23 |
preliminary data | 23 |
might contribute | 23 |
retinoic acid | 23 |
recognition receptors | 23 |
myelinated axons | 23 |
myelin formation | 23 |
term effects | 23 |
also seen | 23 |
will help | 23 |
wilms tumor | 23 |
mediated disease | 23 |
particular interest | 23 |
lesser extent | 23 |
energy metabolism | 23 |
increasing evidence | 23 |
pattern recognition | 23 |
small intestine | 23 |
clinical outcome | 23 |
fear memory | 23 |
one week | 23 |
electrical stimulation | 23 |
mast cells | 22 |
labeled cells | 22 |
synaptic activity | 22 |
cell epitope | 22 |
six cats | 22 |
patients reported | 22 |
clinical management | 22 |
binding site | 22 |
blood contamination | 22 |
cells play | 22 |
primary motor | 22 |
markedly increased | 22 |
fast blue | 22 |
congestive heart | 22 |
nucleus accumbens | 22 |
high level | 22 |
bystander activation | 22 |
may serve | 22 |
median survival | 22 |
scid mice | 22 |
necrotizing encephalopathy | 22 |
also may | 22 |
nervous tissue | 22 |
cell viability | 22 |
gut microbiome | 22 |
derived macrophages | 22 |
organ systems | 22 |
th cm | 22 |
keio univ | 22 |
histological analysis | 22 |
clinical manifestation | 22 |
closely associated | 22 |
mice using | 22 |
day postinfection | 22 |
combination therapy | 22 |
medium containing | 22 |
genes involved | 22 |
fold higher | 22 |
genetic testing | 22 |
physiological conditions | 22 |
older age | 22 |
nerve fibers | 22 |
result suggests | 22 |
electrolyte abnormalities | 22 |
significant changes | 22 |
cell numbers | 22 |
cba mice | 22 |
i antigen | 22 |
electrical activity | 22 |
therapeutic strategy | 22 |
largely unknown | 22 |
united kingdom | 22 |
infl uence | 22 |
green fluorescent | 22 |
affected area | 22 |
ventricular dysrhythmias | 22 |
diaphragmatic hernia | 22 |
genes encoding | 22 |
host disease | 22 |
infected individuals | 22 |
chronic viral | 22 |
viruses may | 22 |
cell membranes | 22 |
animals showed | 22 |
direct effect | 22 |
immune evasion | 22 |
vaccine development | 22 |
mri showed | 22 |
ewing sarcoma | 22 |
trigeminal nerve | 22 |
study period | 22 |
respiratory infection | 22 |
parkinson disease | 22 |
infected cns | 22 |
blood glucose | 22 |
corona virus | 22 |
also play | 22 |
cord tissue | 22 |
months later | 22 |
treatment options | 22 |
action potential | 22 |
results obtained | 22 |
also increased | 22 |
conditioned medium | 22 |
ido expression | 22 |
zikv infection | 22 |
riken bsi | 22 |
neutrophil count | 22 |
neural network | 22 |
adoptively transferred | 22 |
aseptically scrub | 22 |
virus persistence | 22 |
analysis using | 22 |
complete remission | 22 |
th cell | 22 |
neuroprotective effect | 22 |
rat anti | 22 |
cc chemokines | 22 |
molecular cloning | 22 |
presumed secondary | 22 |
induction therapy | 22 |
disease burden | 22 |
null mice | 22 |
retrospective analysis | 22 |
provide evidence | 22 |
factor alpha | 22 |
patients aged | 22 |
focal lesions | 21 |
two years | 21 |
barrier permeability | 21 |
national institutes | 21 |
ace receptor | 21 |
system inflammation | 21 |
cell therapy | 21 |
motor learning | 21 |
functional roles | 21 |
humoral responses | 21 |
lymphocytic pleocytosis | 21 |
human demyelinating | 21 |
gauge needle | 21 |
pulse oximetry | 21 |
cns excitation | 21 |
experimental infection | 21 |
molecular layer | 21 |
vitro stimulation | 21 |
possible involvement | 21 |
transmitter release | 21 |
old boy | 21 |
first line | 21 |
will provide | 21 |
lesion site | 21 |
nerve regeneration | 21 |
scar formation | 21 |
brain swelling | 21 |
antiviral activity | 21 |
muscle tremors | 21 |
serine protease | 21 |
mice also | 21 |
mice may | 21 |
independent experiments | 21 |
pertussis toxin | 21 |
rrms patients | 21 |
several months | 21 |
diagnostic tests | 21 |
receptor gene | 21 |
studies show | 21 |
infected cell | 21 |
exome sequencing | 21 |
successfully treated | 21 |
may influence | 21 |
neurological dysfunction | 21 |
peripheral neuropathy | 21 |
cancer therapy | 21 |
lung disease | 21 |
inflammatory conditions | 21 |
leukocyte infiltration | 21 |
allogeneic hematopoietic | 21 |
induced cns | 21 |
per day | 21 |
prospective studies | 21 |
cell immunity | 21 |
treated rats | 21 |
copy number | 21 |
also show | 21 |
neurologic symptoms | 21 |
table ii | 21 |
cytokine secretion | 21 |
age range | 21 |
recent data | 21 |
jak stat | 21 |
septic shock | 21 |
recent evidence | 21 |
increased numbers | 21 |
primary infection | 21 |
like disease | 21 |
inflammatory lesions | 21 |
system involvement | 21 |
neurological sequelae | 21 |
inhibitory effect | 21 |
three times | 21 |
low cd | 21 |
will also | 21 |
frontal lobe | 21 |
allogeneic hct | 21 |
nb rats | 21 |
approximately one | 21 |
virus spread | 21 |
many years | 21 |
chronic lesions | 21 |
mouse cd | 21 |
motor nucleus | 21 |
abdominal ultrasound | 21 |
blood transfusion | 21 |
studies revealed | 21 |
five cats | 21 |
treg cells | 21 |
response may | 21 |
specific expression | 21 |
seven patients | 21 |
forming cells | 21 |
quantitative analysis | 21 |
well described | 21 |
total body | 21 |
acute inflammation | 21 |
normal csf | 21 |
blast cells | 21 |
present within | 21 |
term memory | 21 |
human cd | 21 |
small bowel | 21 |
extracellular space | 21 |
may suggest | 21 |
one third | 21 |
fos expression | 21 |
survival rate | 21 |
one month | 21 |
embryonic day | 21 |
may involve | 21 |
nucleocapsid protein | 21 |
draining lymph | 21 |
surround suppression | 21 |
kg sq | 21 |
model system | 21 |
da neurons | 21 |
severe anemia | 21 |
herpes zoster | 21 |
positive correlation | 21 |
susceptible individuals | 21 |
induced encephalitis | 21 |
also induced | 20 |
human monocytes | 20 |
sars patients | 20 |
lymphoid tissues | 20 |
enzyme activity | 20 |
highly pathogenic | 20 |
ciliary neurotrophic | 20 |
significantly improved | 20 |
adult human | 20 |
chronic phase | 20 |
nonsteroidal antiinflammatory | 20 |
ischemic injury | 20 |
oxygen delivery | 20 |
clinical presentations | 20 |
transgenic expression | 20 |
effector mechanisms | 20 |
somatosensory cortex | 20 |
ganglion cells | 20 |
neural development | 20 |
hospital medical | 20 |
vascular access | 20 |
myelin repair | 20 |
within minutes | 20 |
neurodegenerative disorder | 20 |
associated protein | 20 |
clinical picture | 20 |
may benefit | 20 |
infect humans | 20 |
adc values | 20 |
tissue repair | 20 |
root ganglion | 20 |
immune privilege | 20 |
mouse line | 20 |
increased cd | 20 |
ionizing radiation | 20 |
toxicity include | 20 |
brain macrophages | 20 |
locus coeruleus | 20 |
genetic susceptibility | 20 |
replacement therapy | 20 |
microglia express | 20 |
autosomal recessive | 20 |
factors may | 20 |
interferon regulatory | 20 |
respiratory illness | 20 |
body mass | 20 |
study also | 20 |
blood stream | 20 |
increased number | 20 |
microglia play | 20 |
glial cultures | 20 |
surgical excision | 20 |
underlying mechanism | 20 |
relapsing multiple | 20 |
rhesus monkeys | 20 |
viral genome | 20 |
synaptic inputs | 20 |
enteric nervous | 20 |
cns remyelination | 20 |
cleveland clinic | 20 |
neural circuits | 20 |
apoptotic cell | 20 |
high resolution | 20 |
high cd | 20 |
solitary tract | 20 |
immunodominant epitope | 20 |
olfactory system | 20 |
specific receptor | 20 |
showed mild | 20 |
six months | 20 |
brain research | 20 |
also possible | 20 |
applied biosystems | 20 |
surgical intervention | 20 |
chest ct | 20 |
regulatory factor | 20 |
gene transcription | 20 |
eae models | 20 |
subarachnoid space | 20 |
among others | 20 |
past years | 20 |
increased production | 20 |
specific cell | 20 |
based protocols | 20 |
specific manner | 20 |
hepatic failure | 20 |
weighted imaging | 20 |
functional expression | 20 |
membrane protein | 20 |
cells using | 20 |
assessed using | 20 |
eye movements | 20 |
autoimmune demyelination | 20 |
neurotropic viral | 20 |
sodium bicarbonate | 20 |
normal range | 20 |
cancer patients | 20 |
mediated damage | 20 |
ii mhc | 20 |
cerebellar cortex | 20 |
large numbers | 20 |
positive astrocytes | 20 |
pv strains | 20 |
function within | 20 |
cells showed | 20 |
igg antibodies | 20 |
complement system | 20 |
pregnant women | 20 |
express mhc | 20 |
astroglial cells | 20 |
killer cell | 20 |
high concentrations | 20 |
two dogs | 20 |
viral invasion | 20 |
significant improvement | 20 |
male rats | 20 |
matched controls | 20 |
matter tracts | 20 |
systemic infection | 20 |
within months | 20 |
mouse strain | 20 |
open reading | 20 |
analysis demonstrated | 20 |
foxp treg | 20 |
beneficial effect | 20 |
western blotting | 20 |
primary astrocytes | 19 |
developmental stages | 19 |
cutaneous lymphoma | 19 |
oncology group | 19 |
facs analysis | 19 |
je mice | 19 |
clinical use | 19 |
mice developed | 19 |
crystalloid fluid | 19 |
medical science | 19 |
eight patients | 19 |
early acute | 19 |
cell division | 19 |
results support | 19 |
presynaptic terminals | 19 |
light microscopy | 19 |
gastroprotectant drugs | 19 |
mice per | 19 |
brain samples | 19 |
wallerian degeneration | 19 |
chemokine gene | 19 |
respiratory virus | 19 |
mice resulted | 19 |
american neurological | 19 |
early response | 19 |
disease characterized | 19 |
possible mechanism | 19 |
borne encephalitis | 19 |
colony stimulating | 19 |
gene transcripts | 19 |
specific binding | 19 |
cm cells | 19 |
examination findings | 19 |
cholinesterase inhibitors | 19 |
cell clone | 19 |
impaired consciousness | 19 |
preliminary results | 19 |
neurologic diseases | 19 |
viral meningitis | 19 |
plga nanoparticles | 19 |
sample size | 19 |
tissue sections | 19 |
immunohistochemical study | 19 |
ido activity | 19 |
initial presentation | 19 |
induced apoptosis | 19 |
free radical | 19 |
acute flaccid | 19 |
receptor agonist | 19 |
cell development | 19 |
neuron cells | 19 |
ethylene glycol | 19 |
significantly greater | 19 |
cognitive decline | 19 |
animal species | 19 |
low doses | 19 |
fatal encephalitis | 19 |
von willebrand | 19 |
primary antibodies | 19 |
rna polymerase | 19 |
monocyte macrophage | 19 |
within weeks | 19 |
possible mechanisms | 19 |
high mortality | 19 |
vascular anomalies | 19 |
disease models | 19 |
ad mice | 19 |
cause demyelination | 19 |
resident cns | 19 |
confocal microscopy | 19 |
cns antigens | 19 |
aspiration pneumonia | 19 |
diseased animals | 19 |
culture conditions | 19 |
sodium channels | 19 |
aged mice | 19 |
cell effector | 19 |
target cell | 19 |
nagoya univ | 19 |
effector phase | 19 |
metropolitan institute | 19 |
respiratory pattern | 19 |
high degree | 19 |
cns immune | 19 |
neurologic signs | 19 |
emergency department | 19 |
cells might | 19 |
induced central | 19 |
also revealed | 19 |
imaging modality | 19 |
vivo studies | 19 |
remitting ms | 19 |
inflammatory monocyte | 19 |
medulla oblongata | 19 |
neurological association | 19 |
synaptic vesicles | 19 |
also result | 19 |
endotracheal tube | 19 |
culture medium | 19 |
retrograde axonal | 19 |
capsid protein | 19 |
leukocyte recruitment | 19 |
functional significance | 19 |
tumour necrosis | 19 |
fat diet | 19 |
cns demyelinating | 19 |
pathological findings | 19 |
respiratory pathogens | 19 |
also detected | 19 |
control seizures | 19 |
cause cns | 19 |
inflammatory bowel | 19 |
infected microglia | 19 |
days prior | 19 |
catheter placement | 19 |
three groups | 19 |
receptor signaling | 19 |
occur within | 19 |
direct ex | 19 |
primary immunodeficiency | 19 |
analgesic drugs | 19 |
successful treatment | 19 |
months post | 19 |
treatment response | 19 |
related disorders | 19 |
receptor site | 19 |
cell functions | 19 |
following mhv | 19 |
marrow transplant | 19 |
reverse transcription | 19 |
observed following | 19 |
hydrogen peroxide | 19 |
using anti | 19 |
phase iii | 19 |
well established | 19 |
per group | 19 |
toxic potential | 19 |
many viruses | 19 |
brain ischemia | 19 |
mediated demyelinating | 19 |
inflammatory effects | 19 |
cancer institute | 19 |
major depression | 19 |
genetic analysis | 19 |
canine lymphoma | 19 |
derived growth | 19 |
cytokine levels | 19 |
fluid analysis | 19 |
climate change | 19 |
pulmonary complications | 19 |
mental retardation | 19 |
cns symptoms | 19 |
life sciences | 19 |
mutant mouse | 19 |
inflammatory csf | 18 |
acute leukemia | 18 |
wound healing | 18 |
red cell | 18 |
systemic chemotherapy | 18 |
intercostal space | 18 |
viral model | 18 |
term follow | 18 |
respiratory coronaviruses | 18 |
immediate early | 18 |
least two | 18 |
cultured hippocampal | 18 |
enhancing lesions | 18 |
mapk pathway | 18 |
mixed glial | 18 |
immune signaling | 18 |
reactive astrogliosis | 18 |
small cell | 18 |
month old | 18 |
animal care | 18 |
alimentary lymphoma | 18 |
review will | 18 |
old mice | 18 |
peripheral myelin | 18 |
intraocular pressure | 18 |
targeted therapies | 18 |
affected animals | 18 |
functional outcome | 18 |
well defined | 18 |
beta interferon | 18 |
myocardial infarction | 18 |
virus infects | 18 |
tropical spastic | 18 |
persistent virus | 18 |
complete resolution | 18 |
times post | 18 |
one report | 18 |
affective disorders | 18 |
neonatal rat | 18 |
results revealed | 18 |
specific gene | 18 |
primary cause | 18 |
cns autoimmunity | 18 |
slice culture | 18 |
mice results | 18 |
mouse central | 18 |
using flow | 18 |
inflammatory changes | 18 |
brain infection | 18 |
less commonly | 18 |
envelope glycoproteins | 18 |
intracerebral inoculation | 18 |
responses following | 18 |
pain control | 18 |
pulmonary hypertension | 18 |
causative agent | 18 |
acute encephalopathy | 18 |
cultured cortical | 18 |
varicella zoster | 18 |
demyelinating disorders | 18 |
kidney injury | 18 |
celiac disease | 18 |
radial glia | 18 |
medical record | 18 |
virus infected | 18 |
hev infection | 18 |
virus vaccine | 18 |
small molecule | 18 |
luxol fast | 18 |
factors including | 18 |
spinal canal | 18 |
vod sos | 18 |
blood monocytes | 18 |
old woman | 18 |
gut microbiota | 18 |
first days | 18 |
mood disorders | 18 |
myelinating schwann | 18 |
drug metabolism | 18 |
lateral ventricle | 18 |
axon terminals | 18 |
myelinated fibers | 18 |
clinical significance | 18 |
flow cytometer | 18 |
preclinical studies | 18 |
different time | 18 |
cases may | 18 |
cancer diagnosis | 18 |
neural tissue | 18 |
thiamine deficiency | 18 |
late chronic | 18 |
also induce | 18 |
also associated | 18 |
vascular permeability | 18 |
whole exome | 18 |
hematopoietic cells | 18 |
alternative splicing | 18 |
hypovolemic shock | 18 |
behavioral changes | 18 |
mice immunized | 18 |
highly conserved | 18 |
cfa containing | 18 |
molecular profile | 18 |
following exposure | 18 |
receptor sites | 18 |
respiratory rate | 18 |
conduction block | 18 |
rating scale | 18 |
regulatory mechanisms | 18 |
virus rna | 18 |
cell interactions | 18 |
dominant negative | 18 |
vascular endothelium | 18 |
mhc ii | 18 |
may increase | 18 |
food intake | 18 |
specific memory | 18 |
vena cava | 18 |
acute necrotizing | 18 |
may present | 18 |
abdominal radiographs | 18 |
positive results | 18 |
every hours | 18 |
cellular infiltration | 18 |
study aimed | 18 |
human fetal | 18 |
different stages | 18 |
contrast enhanced | 18 |
soluble factors | 18 |
cns depression | 18 |
induction chemotherapy | 18 |
constant rate | 18 |
useful tool | 18 |
globus pallidus | 18 |
residual disease | 18 |
experimental model | 18 |
ifnar signaling | 18 |
intranasal infection | 18 |
storage diseases | 18 |
tissue factor | 18 |
familial hlh | 18 |
ctl epitopes | 18 |
intercellular adhesion | 18 |
molecular characterization | 18 |
critical period | 18 |
brain endothelial | 18 |
may improve | 18 |
may indicate | 18 |
cultured cells | 18 |
binding domain | 18 |
underlying disease | 18 |
well characterized | 18 |
feline coronavirus | 18 |
memory cells | 18 |
immunoglobulin superfamily | 18 |
visual information | 18 |
cells present | 18 |
resting state | 18 |
granulation tissue | 18 |
small amounts | 18 |
rat hippocampus | 18 |
contrast enhancement | 18 |
might also | 18 |
kainic acid | 18 |
evaluated using | 17 |
cerebellar purkinje | 17 |
spatial learning | 17 |
glutamic acid | 17 |
human microglia | 17 |
acute hemorrhagic | 17 |
critical roles | 17 |
wildtype mice | 17 |
cortical astrocytes | 17 |
brainstem encephalitis | 17 |
point mutation | 17 |
disease induced | 17 |
cough reflex | 17 |
cutting edge | 17 |
muscle cells | 17 |
unpublished data | 17 |
herpes virus | 17 |
cases reported | 17 |
allowed us | 17 |
derived microglia | 17 |
specific genes | 17 |
pharmaceutical sciences | 17 |
particularly important | 17 |
may produce | 17 |
immune mediated | 17 |
signs may | 17 |
mammalian brain | 17 |
cell recognition | 17 |
randomized controlled | 17 |
retrospectively reviewed | 17 |
sensitive dye | 17 |
oligodendrocyte death | 17 |
patch clamp | 17 |
cells produce | 17 |
severe combined | 17 |
past decade | 17 |
cell lineage | 17 |
chemokine cxcl | 17 |
lethal jhmv | 17 |
later stages | 17 |
intranasal administration | 17 |
year post | 17 |
perivascular macrophages | 17 |
hlh group | 17 |
therapeutic options | 17 |
acute inflammatory | 17 |
cognitive dysfunction | 17 |
cognitive functions | 17 |
maintenance therapy | 17 |
memory formation | 17 |
calcium channel | 17 |
neurological disorder | 17 |
viral gene | 17 |
normal appearing | 17 |
less frequently | 17 |
two decades | 17 |
simplex encephalitis | 17 |
clinically isolated | 17 |
also contribute | 17 |
mixed agonist | 17 |
expression within | 17 |
cytotoxic cd | 17 |
tap water | 17 |
cord lesions | 17 |
coronavirus spike | 17 |
cell patch | 17 |
included patients | 17 |
induced disease | 17 |
bmem conversion | 17 |
warm water | 17 |
like growth | 17 |
japan science | 17 |
toxic dose | 17 |
gfp mice | 17 |
systemic disease | 17 |
throughout infection | 17 |
rhesus macaques | 17 |
tyrosine hydroxylase | 17 |
previous reports | 17 |
body surface | 17 |
recombinant vaccinia | 17 |
nerve cells | 17 |
national cancer | 17 |
several weeks | 17 |
buffered saline | 17 |
th th | 17 |
visual stimuli | 17 |
including cd | 17 |
dth responses | 17 |
activated protein | 17 |
quantitative rt | 17 |
cell phenotype | 17 |
associated coronavirus | 17 |
causes neuronal | 17 |
mesenchymal stem | 17 |
primary cultured | 17 |
unpublished observations | 17 |
cingulate cortex | 17 |
glucose metabolism | 17 |
translocator protein | 17 |
dipeptidyl peptidase | 17 |
immune systems | 17 |
cns invasion | 17 |
normal cns | 17 |
cns autoimmune | 17 |
clinical scores | 17 |
predominantly expressed | 17 |
active lesions | 17 |
hippocampal slice | 17 |
chlamydia pneumoniae | 17 |
cient mice | 17 |
cell accumulation | 17 |
ms may | 17 |
rna sequencing | 17 |
viral ag | 17 |
cov may | 17 |
catheter hub | 17 |
dna viruses | 17 |
human patients | 17 |
ca channel | 17 |
multicenter study | 17 |
organ damage | 17 |
mrna level | 17 |
relapsing eae | 17 |
restricted cytotoxic | 17 |
late effects | 17 |
mildly elevated | 17 |
associated acute | 17 |
potential targets | 17 |
neural progenitors | 17 |
logistic regression | 17 |
cell reactivity | 17 |
molecular level | 17 |
environmental risk | 17 |
infected rl | 17 |
located within | 17 |
hematologic malignancies | 17 |
virus replicates | 17 |
pediatric radiologists | 17 |
experimental studies | 17 |
lumbar csf | 17 |
may show | 17 |
antiinflammatory drugs | 17 |
physiological sciences | 17 |
glioma cell | 17 |
disease processes | 17 |
inflammatory reactions | 17 |
oncotic pressure | 17 |
gc reactions | 17 |
first time | 17 |
platelet function | 17 |
diagnostic accuracy | 17 |
measured using | 17 |
balamuthia mandrillaris | 17 |
drug administration | 17 |
liver biopsy | 17 |
two main | 17 |